Document is current
Any future updates will be listed below
-
Authors
Soranno, Danielle E. https://orcid.org/0000-0001-7019-809X
Amaral, Sandra
Ashoor, Isa
Atkinson, Meredith A.
Barletta, Gina-Marie
Braun, Michael C.
Carlson, Joann
Carter, Caitlin
Chua, Annabelle
Dharnidharka, Vikas R.
Drake, Keri
Erkan, Elif
Feig, Dan
Goldstein, Stuart L.
Hains, David
Harshman, Lyndsay A.
Ingulli, Elizabeth
Kula, Alexander J.
Leonard, Mary
Mannemuddhu, Sudha
Menon, Shina
Modi, Zubin J.
Moxey-Mims, Marva
Nada, Arwa
Norwood, Victoria
Starr, Michelle C.
Verghese, Priya S.
Weidemann, Darcy
Weinstein, Adam
Smith, Jodi
-
Funding
Funding for this research was provided by:
ASPN Foundation (Foundation support)
- License Information
-
More Information
Article History
Received: 4 March 2024
Revised: 23 April 2024
Accepted: 11 May 2024
First Online: 8 July 2024
Declarations
:
: The authors report no relevant conflicts of interest that could have appeared to influence the work reported in this paper. Sandra Amaral reports a relationship with Bristol Myers Squibb Co that includes consulting or advisory. Isa Ashoor reports a relationship with The American Board of Pediatrics that includes board membership. Meredith Atkinson reports a relationship with GlaxoSmithKline Inc. that includes consulting or advisory. Michael Braun reports a relationship with The American Board of Pediatrics that includes board membership. Annabelle Chua reports a relationship with Akebia Therapeutics Inc. that includes board membership and consulting or advisory. Annabelle Chua reports a relationship with The American Board of Pediatrics that includes board membership. Shina Menon reports a relationship with Medtronic Inc. that includes consulting or advisory. Shina Menon reports a relationship with Nuwellis Inc. that includes consulting or advisory. Victoria Norwood reports a relationship with The American Board of Pediatrics that includes board membership. Victoria Norwood reports a relationship with National Academies of Sciences Engineering and Medicine that includes board membership. Stuart Goldstein reports a relationship with BioPorto Diagnostics Inc. that includes consulting or advisory.
